Intriguingly, a similar upregulation was observed in muscle biopsies from patients with cachexia due to pancreatic and colorectal cancer.1 This observation not only points to a potential role for EDA2R-mediated muscle loss across different types of malignancies but also suggests the possibility of translational applications. This evidence concerns the gene EDA2R and Cachexia.